INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
Subscribe
INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
SEARCH
SEARCH
advanced search
Connecting Drug Delivery
121
Issue No #121 Jun/Jul 2021
June 30th, 2021
Download PDF
Issue 121 - Jun 2021
Inside the magazine
CONNECTIVITY
Arnaud Guillet
Biocorp
BIOCORP’S MALLYA – CHRONICLING A SUCCESS STORY
Arnaud Guillet and colleagues from across the industry, discuss Bicorp’s Mallya add-on device for disposable insulin pens, providing details on the main country launches and key software integrations, as well as presenting initial feedback from healthcare professionals and patients.
CONNECTIVITY
Napoleon Monroe
New Directions Technology Consulting
PATENTS ARE IMPORTANT FOR SMART HEALTHCARE PRODUCTS
Napoleon Monroe discusses the value of internet-connected smart devices in present-day healthcare, and introduces the mMed patent portfolio, of which Mr Monroe is the sole inventor, and which contains five US patents for key connected health technologies.
EXPERT VIEW
Dr Ben Cox
THE POWER OF ONBOARDING: BUILDING PERSUASIVE USER EXPERIENCES FOR COMPANION APPS
Ben Cox discusses the value of onboarding in drug delivery device companion apps, and how it is a key component of converting a one-time user to a repeat user, unlocking the true value of companion apps as a tool for combating poor adherence to medications and gathering high-quality data.
CONNECTIVITY
Josh Hopkins
Noble
HOW DIGITAL MEDICAL DEVICES ARE MEETING THE CHALLENGES OF CLINICAL TRIALS
Josh Hopkins discusses the challenges that have been present in conducting clinical trials at a central brick-and-mortar location since their inception, and how modern digitisation presents an opportunity to improve clinical trial methodology by liberating it from the need for an in-person central study site via the use of digital medical devices and technologies.
CONNECTIVITY
Matthew Sarkar
Sagentia Innovation
IMPROVING PATIENT OUTCOMES WITH ADVANCED DIGITAL BIOMARKERS
Matthew Sarkar and Imantha Samaranayake consider the contribution digital biomarker devices make towards healthcare and the challenges faced by the evolution of such devices.
CONNECTIVITY
Christina Philpott
MEANING-CENTRED PRODUCT DEVELOPMENT: THE KEY TO SUCCESSFUL CONNECTED DISEASE MANAGEMENT
Christina Philpott, Miles Hawley and Natasha French, discuss the future of connected disease management and the potential benefits for asthma treatment.
CONNECTIVITY
John Whitehouse
DCA
CYBERSECURITY AND CONNECTED DRUG DELIVERY – AN INTEGRATED RISK-BASED APPROACH
John Whitehouse, Rob Veasey and Shane Day, discuss the value of integrating cybersecurity into a holistic, multidisciplinary approach to risk management for connected medical devices.
CONNECTIVITY
Adam Shain
Aptar Pharma
PUTTING THEIR HEALTH IN THEIR HANDS: ENHANCING RESPIRATORY PATIENT OUTCOMES THROUGH DIGITAL THERAPEUTICS
Adam Shain discusses the role digital therapeutics play in respiratory patient outcomes and looks at the potential for expansion into other therapy areas.
CONNECTIVITY
Dr Young Kim
Celanese
SPECIALTY LCP COMPOUNDS FOR ELECTRONICS INTEGRATION IN CONNECTED MEDICAL DEVICES
Young Kim, Don DeMello and Philip Wilson, discuss the benefits of recent advances in liquid crystal polymer for connected medical devices.
Top
